nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—Lethargy—Prednisone—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Dicyclomine—Muscular weakness—Betamethasone—psoriatic arthritis	0.00408	0.00408	CcSEcCtD
Dicyclomine—Muscular weakness—Dexamethasone—psoriatic arthritis	0.00408	0.00408	CcSEcCtD
Dicyclomine—Affect lability—Prednisone—psoriatic arthritis	0.00397	0.00397	CcSEcCtD
Dicyclomine—Thrombophlebitis—Methotrexate—psoriatic arthritis	0.00389	0.00389	CcSEcCtD
Dicyclomine—Face oedema—Prednisone—psoriatic arthritis	0.00389	0.00389	CcSEcCtD
Dicyclomine—Mood swings—Prednisone—psoriatic arthritis	0.00382	0.00382	CcSEcCtD
Dicyclomine—Muscular weakness—Prednisone—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Dicyclomine—Abdominal distension—Prednisone—psoriatic arthritis	0.00351	0.00351	CcSEcCtD
Dicyclomine—Hallucination—Methylprednisolone—psoriatic arthritis	0.0035	0.0035	CcSEcCtD
Dicyclomine—Lethargy—Methotrexate—psoriatic arthritis	0.00344	0.00344	CcSEcCtD
Dicyclomine—Erythema—Prednisolone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Dicyclomine—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Dicyclomine—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Dicyclomine—Erectile dysfunction—Prednisone—psoriatic arthritis	0.00321	0.00321	CcSEcCtD
Dicyclomine—Mood swings—Methotrexate—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Dicyclomine—Hallucination—Betamethasone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Dicyclomine—Hallucination—Dexamethasone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Dicyclomine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00318	0.00318	CcSEcCtD
Dicyclomine—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Dicyclomine—Vision blurred—Prednisolone—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Dicyclomine—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Dicyclomine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Dicyclomine—Erythema—Triamcinolone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Dicyclomine—Erythema—Methylprednisolone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Dicyclomine—Angioedema—Prednisolone—psoriatic arthritis	0.00305	0.00305	CcSEcCtD
Dicyclomine—Breast disorder—Methotrexate—psoriatic arthritis	0.00305	0.00305	CcSEcCtD
Dicyclomine—Malaise—Prednisolone—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Dicyclomine—Syncope—Prednisolone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Dicyclomine—Eye disorder—Dexamethasone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Dicyclomine—Eye disorder—Betamethasone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Dicyclomine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00294	0.00294	CcSEcCtD
Dicyclomine—Hypertension—Prednisolone—psoriatic arthritis	0.00289	0.00289	CcSEcCtD
Dicyclomine—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Dicyclomine—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Dicyclomine—Discomfort—Prednisolone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Dicyclomine—Angioedema—Triamcinolone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Dicyclomine—Angioedema—Methylprednisolone—psoriatic arthritis	0.0028	0.0028	CcSEcCtD
Dicyclomine—Erythema—Betamethasone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Dicyclomine—Erythema—Dexamethasone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Dicyclomine—Hallucination—Prednisone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Dicyclomine—Malaise—Triamcinolone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Dicyclomine—Malaise—Methylprednisolone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Dicyclomine—Syncope—Triamcinolone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Dicyclomine—Syncope—Methylprednisolone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Dicyclomine—Oedema—Prednisolone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Dicyclomine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Dicyclomine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Dicyclomine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Dicyclomine—Shock—Prednisolone—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Dicyclomine—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Dicyclomine—Tachycardia—Prednisolone—psoriatic arthritis	0.00266	0.00266	CcSEcCtD
Dicyclomine—Hypertension—Triamcinolone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Dicyclomine—Hypertension—Methylprednisolone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Dicyclomine—Eye disorder—Prednisone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Dicyclomine—Drowsiness—Methotrexate—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Dicyclomine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Dicyclomine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Dicyclomine—Discomfort—Triamcinolone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Dicyclomine—Discomfort—Methylprednisolone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Dicyclomine—Dry mouth—Triamcinolone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Dicyclomine—Angioedema—Dexamethasone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Dicyclomine—Angioedema—Betamethasone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Dicyclomine—Confusional state—Methylprednisolone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Dicyclomine—Immune system disorder—Prednisone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Dicyclomine—Malaise—Dexamethasone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Dicyclomine—Malaise—Betamethasone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Dicyclomine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Dicyclomine—Oedema—Triamcinolone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Dicyclomine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Dicyclomine—Syncope—Betamethasone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Dicyclomine—Syncope—Dexamethasone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Dicyclomine—Shock—Triamcinolone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Dicyclomine—Insomnia—Prednisolone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Dicyclomine—Shock—Methylprednisolone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Dicyclomine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Dicyclomine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Dicyclomine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Dicyclomine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Dicyclomine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Dicyclomine—Mental disorder—Prednisone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Dicyclomine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Dicyclomine—Erythema—Prednisone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Dicyclomine—Hypertension—Dexamethasone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Dicyclomine—Hypertension—Betamethasone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Dicyclomine—Discomfort—Dexamethasone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Dicyclomine—Discomfort—Betamethasone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Dicyclomine—Pain—Prednisolone—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Dicyclomine—Vision blurred—Prednisone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Dicyclomine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Dicyclomine—Oedema—Betamethasone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Dicyclomine—Oedema—Dexamethasone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Dicyclomine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Dicyclomine—Insomnia—Triamcinolone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Dicyclomine—Insomnia—Methylprednisolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Dicyclomine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Dicyclomine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Dicyclomine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Dicyclomine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Dicyclomine—Shock—Betamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Dicyclomine—Shock—Dexamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Dicyclomine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Dicyclomine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Dicyclomine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Dicyclomine—Agitation—Prednisone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Dicyclomine—Tachycardia—Dexamethasone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Dicyclomine—Tachycardia—Betamethasone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Dicyclomine—Angioedema—Prednisone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Dicyclomine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Dicyclomine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Dicyclomine—Malaise—Prednisone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Dicyclomine—Eye disorder—Methotrexate—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Dicyclomine—Syncope—Prednisone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Dicyclomine—Anorexia—Dexamethasone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Dicyclomine—Anorexia—Betamethasone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Dicyclomine—Urticaria—Prednisolone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Dicyclomine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Dicyclomine—Fatigue—Triamcinolone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Dicyclomine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Dicyclomine—Pain—Triamcinolone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Dicyclomine—Loss of consciousness—Prednisone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Dicyclomine—Immune system disorder—Methotrexate—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Dicyclomine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Dicyclomine—Hypertension—Prednisone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Dicyclomine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Dicyclomine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Dicyclomine—Insomnia—Dexamethasone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Dicyclomine—Insomnia—Betamethasone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Dicyclomine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Dicyclomine—Paraesthesia—Betamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Dicyclomine—Discomfort—Prednisone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Dicyclomine—Mental disorder—Methotrexate—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Dicyclomine—Erythema—Methotrexate—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Dicyclomine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Dicyclomine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Dicyclomine—Dyspepsia—Betamethasone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Dicyclomine—Urticaria—Triamcinolone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Dicyclomine—Urticaria—Methylprednisolone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Dicyclomine—Oedema—Prednisone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Dicyclomine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Dicyclomine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Dicyclomine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Dicyclomine—Decreased appetite—Betamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Dicyclomine—Fatigue—Dexamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Dicyclomine—Fatigue—Betamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Dicyclomine—Shock—Prednisone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Dicyclomine—Pain—Dexamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Dicyclomine—Pain—Betamethasone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Dicyclomine—Nervous system disorder—Prednisone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Dicyclomine—Tachycardia—Prednisone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Dicyclomine—Vision blurred—Methotrexate—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Dicyclomine—Anorexia—Prednisone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Dicyclomine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Dicyclomine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Dicyclomine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Dicyclomine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Dicyclomine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Dicyclomine—Malaise—Methotrexate—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Dicyclomine—Urticaria—Dexamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Dicyclomine—Urticaria—Betamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Dicyclomine—Dizziness—Prednisolone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Dicyclomine—Asthenia—Triamcinolone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Dicyclomine—Abdominal pain—Betamethasone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Dicyclomine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Dicyclomine—Asthenia—Methylprednisolone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Dicyclomine—Insomnia—Prednisone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Dicyclomine—Paraesthesia—Prednisone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Dicyclomine—Pruritus—Triamcinolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Dicyclomine—Pruritus—Methylprednisolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Dicyclomine—Dyspepsia—Prednisone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Dicyclomine—Decreased appetite—Prednisone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Dicyclomine—Rash—Prednisolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Dicyclomine—Dermatitis—Prednisolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Dicyclomine—Fatigue—Prednisone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Dicyclomine—Headache—Prednisolone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Dicyclomine—Discomfort—Methotrexate—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Dicyclomine—Constipation—Prednisone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Dicyclomine—Confusional state—Methotrexate—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Dicyclomine—Dizziness—Triamcinolone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Dicyclomine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Dicyclomine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Dicyclomine—Feeling abnormal—Prednisone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Dicyclomine—Asthenia—Dexamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Dicyclomine—Asthenia—Betamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Dicyclomine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Dicyclomine—Nausea—Prednisolone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Dicyclomine—Pruritus—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Dicyclomine—Pruritus—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Dicyclomine—Vomiting—Triamcinolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Dicyclomine—Vomiting—Methylprednisolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Dicyclomine—Rash—Triamcinolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Dicyclomine—Dermatitis—Triamcinolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Dicyclomine—Anorexia—Methotrexate—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Dicyclomine—Rash—Methylprednisolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Dicyclomine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Dicyclomine—Urticaria—Prednisone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Dicyclomine—Headache—Triamcinolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Dicyclomine—Headache—Methylprednisolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Dicyclomine—Abdominal pain—Prednisone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Dicyclomine—Dizziness—Dexamethasone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Dicyclomine—Dizziness—Betamethasone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Dicyclomine—Insomnia—Methotrexate—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Dicyclomine—Nausea—Triamcinolone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Dicyclomine—Paraesthesia—Methotrexate—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Dicyclomine—Nausea—Methylprednisolone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Dicyclomine—Dyspnoea—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Dicyclomine—Somnolence—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Dicyclomine—Hypersensitivity—Prednisone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Dicyclomine—Dyspepsia—Methotrexate—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Dicyclomine—Vomiting—Betamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Dicyclomine—Vomiting—Dexamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Dicyclomine—Decreased appetite—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Dicyclomine—Rash—Betamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Dicyclomine—Rash—Dexamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Dicyclomine—Dermatitis—Dexamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Dicyclomine—Dermatitis—Betamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Dicyclomine—Fatigue—Methotrexate—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Dicyclomine—Headache—Dexamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Dicyclomine—Headache—Betamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Dicyclomine—Asthenia—Prednisone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Dicyclomine—Pain—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Dicyclomine—Pruritus—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Dicyclomine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Dicyclomine—Nausea—Dexamethasone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Dicyclomine—Nausea—Betamethasone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Dicyclomine—Urticaria—Methotrexate—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Dicyclomine—Dizziness—Prednisone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Dicyclomine—Abdominal pain—Methotrexate—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Dicyclomine—Vomiting—Prednisone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Dicyclomine—Rash—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Dicyclomine—Dermatitis—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Dicyclomine—Headache—Prednisone—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Dicyclomine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Dicyclomine—Asthenia—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Dicyclomine—Nausea—Prednisone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Dicyclomine—Pruritus—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Dicyclomine—Dizziness—Methotrexate—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Dicyclomine—Vomiting—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Dicyclomine—Rash—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Dicyclomine—Dermatitis—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Dicyclomine—Headache—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Dicyclomine—Nausea—Methotrexate—psoriatic arthritis	0.000984	0.000984	CcSEcCtD
